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SUMMARY
Swallowing difficulties in older adults present challenges for medication management, particularly 
as polypharmacy is so common.
It is also important to review the patient’s swallowing difficulties and medication management 
regularly. The limited availability of oral liquids and other dosage forms given by alternative routes 
means that crushing tablets and emptying capsules is common practice.
Altering dosage forms can have adverse clinical consequences. It is important to consider whether 
the medicines are still necessary.
If the medicines are essential, find out if there are alternative formulations. Check guidelines and 
the product information before altering dosage forms.
The legal implications of altering dosage forms can be minimised by following evidence-based 
practice, clearly documenting the reason for altering the medicine and obtaining written 
consent from the patient or their carer. Review the patient’s swallowing ability and treatment 
regimen regularly.
Altering dosage forms for older adults
 • checking if another drug in the same class is 
available in a different dosage form
 • considering extemporaneously compounded 
medicine – this remains off-label use but is 
produced using an evidence-based approach
 • trialling medication lubricants
 • improving swallowing function with the aid of 
speech pathologists.
Information on appropriate 
dosage-form alterations
Often medication errors and unsafe medication use 
occur when dosage forms are altered because of 
limitations in health professionals’ knowledge and 
the lack of availability of guidelines or appropriate 
reference materials.6 The Society of Hospital 
Pharmacists of Australia has produced the Australian 
Don’t Rush to Crush Handbook to assist with 
appropriate dosage-form modification.9 (Similar 
information is also available as an add-on through 
MIMS.) The handbook recommends five primary 
methods of managing a medicine that cannot be 
swallowed whole.9 These include:
 • dispersing a suitable tablet or capsule in water
 • crushing a suitable tablet
 • giving an oral liquid form
 • prescribing an alternative medicine
 • consulting a compounding pharmacy about the 
availability of other formulations.
Introduction
Polypharmacy, dysphagia and age-related 
pathological changes in older adults present 
challenges for medication management. As many as 
one in five older patients has difficulty swallowing and 
may have problems taking tablets and capsules.1,2
The limited availability of oral liquids, patches and 
suppositories means that crushing tablets and 
emptying powder from capsules is very common, 
particularly in aged-care facilities and nursing 
homes.3-6 Multiple medicines are often crushed 
together and mixed with a food or a thickening agent 
for administration.3 Altering solid dosage forms is 
associated with a number of problems.
The stability and bioavailability of drugs can be 
significantly changed by the simple act of crushing 
a tablet, preparing an oral liquid from a tablet or 
capsule, or mixing a crushed tablet or capsule powder 
with food or other thickening agents.7
Manipulating solid dosage forms remains a significant 
source of medication error and harm to patients.7 
It may also result in non-adherence such as missed 
doses or discontinuation of medicines.1,2
Supporting patients with dysphagia
When faced with a patient who is unable to swallow 
solid dosage forms, consider the following:8
 • stopping unnecessary medicines
 • finding an alternative commercially available 
dosage form, for example liquid dosage form
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Some examples of suitable alternatives when drugs 
cannot be modified are described in the Table.9 
Additionally, there have been significant developments in 
both transdermal drug delivery and orally disintegrating 
dosage forms (e.g. olanzapine wafers) which are easily 
administered to patients with swallowing difficulties.
Bioavailability and stability 
considerations
Bioavailability represents the amount of drug that 
reaches the systemic circulation and elicits an effect.6 
The rate and extent of drug released from the 
formulation may be altered by the crushing process, 
resulting in potential changes in the concentration–
time profile.6 Crushing solid dosage forms may also 
enhance dissolution and increase bioavailability. For 
example, if controlled-release opioids are crushed, 
there is a risk of dose dumping and overdose.6 
Alternatively, crushing may lower the dose because of 
drug loss during preparation and administration.9-12
Controlled-release, slow-release and extended-release 
products are specifically designed to deliver the drug 
over a prolonged period of time.6 If a controlled-
release formulation is crushed, the duration of the 
drug’s activity is reduced and the entire quantity of 
the drug may be immediately released resulting in 
toxicity.6 Crushing enteric-coated medicines that are 
acid labile will damage the coating and expose the 
drug to the acidic stomach environment. This may 
have a two-fold effect of irritating the stomach lining 
and causing discomfort, or inactivating the drug if it is 
extremely susceptible to acid degradation.9
Mixing formulations with foods 
and thickeners
Crushed tablets and capsule contents are 
commonly mixed with food to assist with both 
drug administration and adherence. In studies of 
various health facilities, 23–96% of patients were 
given at least one medicine daily mixed into their 
food or beverage to mask the unpleasant taste.3,5,10 
Common foods and beverages used included fruit 
juices, apple sauce, milk, jams, custards, yoghurt, 
honey, pudding and in one case sprinkled on a 
patient’s toast.5,6,9,13
Dissolution, which is required before a drug can 
be absorbed, has been investigated when solid 
dosage forms were crushed in orange juice, honey, 
jam, yoghurt and a commercial powder thickener.11,12 
Although yoghurt is often used as a vehicle for 
mixing and administering crushed tablets, this is 
controversial as it may affect drug dissolution.12 
The adhesive properties of honey and jam may not 
significantly affect dissolution, but they can be 
sticky in the mouth and their high sugar content 
can cause dental problems and affect a patient’s 
glycaemic control.12
Potential complexation of the drug with the food or 
an alteration of the pH environment (which can affect 
drug stability) may also alter a drug’s therapeutic 
effect.6 Accurate dosing is also difficult to achieve if 
patients do not finish their food.12 Additionally, adding 
medicines to food and drink may discourage patients 
from eating.14
Altering dosage forms for older adults
Table    Examples of drugs unsuitable for dosage-form modification and 
suitable alternatives9
Drug Suitable alternative
Enteric-coated drugs
Proton pump inhibitors Oral granules or dispersible form
Sulfasalazine EN tablets 500 mg Sulfasalazine tablets 500 mg (plain)
Slow-release/controlled-release drugs
Metformin 500 mg/1000 mg extended-release tablet Metformin 500 mg tablet (plain)
Ferrous sulfate 325 mg modified-release tablet Ferrous sulfate 150 mg/5 mL liquid
Paracetamol 665 mg controlled-release film-coated tablets Paracetamol 500 mg tablets (plain or dispersible form)
Gliclazide 30 mg/60 mg modified-release tablet Gliclazide 80 mg tablet (plain)
Dabigatran 75 mg/110 mg/150 mg capsule No alternative formulation available – consider other 
anticoagulants
Reference 9 provides a comprehensive list for prescribers to refer to.
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Legal implications
Health professionals who modify formulations have 
both legal and clinical implications to consider (Box). 
Administration of any medicine that has been altered 
from the licensed (original) dosage form by any health 
professional is considered off-label use and has liability 
consequences.9 As modification produces neither 
an approved or labelled product, administration, 
particularly if mixed with food or a thickening agent 
could be seen as unlawful practice.7 In some cases 
dosage-form modification may be occurring without 
the knowledge or authorisation of the prescriber.2
Potential liability may be minimised by:9
 • clearly documenting the reason for altering 
the medicine
 • following evidence-based, safe and effective 
practice
 • obtaining written consent from the consumer or 
legal guardian where possible
 • regularly reviewing the swallowing ability 
of patients and discussing medication 
management needs.
Conclusion
Older adults make up 20% of the population, but 
take 50% of all prescribed medicines. Consequently, 
the bioavailability, stability, safety, clinical and legal 
impacts of drug administration and alteration require 
careful consideration.
The following recommendations may be used as a 
guide if patients are having swallowing difficulties:
 • consider appropriate alternative medicines 
and formulations
 • use guidelines, references or product information 
before authorising medicines to be crushed
 • evaluate the patient’s ability to swallow dosage 
forms regularly. 
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Box    Clinical and legal implications of altering solid 
dosage forms7,9
Clinical implications (examples)
Increased toxicity (crushing extended-release products results in dose dumping)
Medication errors
Reduced efficacy (crushing enteric-coated tablets may result in the drug being 
destroyed by stomach acid)
Instability of the drug (pharmacokinetic changes)
Unpalatability (resulting in non-adherence)
Potential risk to healthcare workers (exposure to cytotoxic drugs)
Unintended aspiration (patient with dysphagia aspirating a medicine)
Incorrect dosage administration (loss of drug during crushing process)
Legal and professional implications (examples)
Off-label drug use (opening a capsule or crushing a tablet before administration)
Lack of consent for administration (patient may be unaware of medication provided 
in food)
Cross contamination (one crushing device being used for multiple patients’ medicines, 
placing patients at risk of adverse effects such as allergic reactions)
